Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
29-Sep-2025 | 1,585.5 | 1,603.5 | 1,566 | 1,578.1 | 17,488 | 10,76,68,803.7 | 37,177 |
30-Sep-2025 | 1,580 | 1,597.1 | 1,569.1 | 1,585.9 | 13,267 | 38,20,15,659.5 | 2,13,926 |
01-Oct-2025 | 1,585 | 1,631.3 | 1,584.9 | 1,624.9 | 13,846 | 10,73,95,831.1 | 34,868 |
03-Oct-2025 | 1,625 | 1,637 | 1,587.6 | 1,593.3 | 16,608 | 27,46,38,145.8 | 1,30,783 |
06-Oct-2025 | 1,580 | 1,617.2 | 1,580 | 1,607.2 | 12,092 | 7,54,87,936.7 | 21,261 |
07-Oct-2025 | 1,615.7 | 1,628.8 | 1,587.3 | 1,598.2 | 10,836 | 18,42,23,179.8 | 84,003 |
08-Oct-2025 | 1,592 | 1,607.8 | 1,584 | 1,600.8 | 15,066 | 15,42,67,223.1 | 68,442 |
09-Oct-2025 | 1,615 | 1,617.9 | 1,585.6 | 1,592.4 | 8,687 | 7,69,42,109.9 | 27,635 |
10-Oct-2025 | 1,599 | 1,614.5 | 1,588.4 | 1,596 | 8,835 | 10,10,24,183.7 | 42,804 |
13-Oct-2025 | 1,592 | 1,618.3 | 1,579.9 | 1,610.1 | 19,722 | 41,29,77,689.4 | 1,99,828 |
14-Oct-2025 | 1,618 | 1,618.6 | 1,573.3 | 1,599.4 | 11,329 | 15,18,34,443.3 | 62,565 |
15-Oct-2025 | 1,598 | 1,618.2 | 1,575.1 | 1,584.1 | 11,679 | 7,28,87,761.8 | 23,673 |
16-Oct-2025 | 1,585 | 1,595 | 1,575 | 1,587 | 14,033 | 23,75,02,367.7 | 1,08,822 |
17-Oct-2025 | 1,571 | 1,609.3 | 1,571 | 1,596.4 | 21,851 | 12,80,53,361.8 | 57,896 |
20-Oct-2025 | 1,573.3 | 1,608 | 1,520 | 1,602.6 | 41,118 | 29,46,73,525.7 | 87,200 |
21-Oct-2025 | 1,585 | 1,609 | 1,579.6 | 1,585.5 | 2,913 | 3,05,08,159.3 | 7,871 |
23-Oct-2025 | 1,610 | 1,610.3 | 1,582.7 | 1,589.6 | 12,481 | 8,30,08,757.6 | 32,391 |
24-Oct-2025 | 1,597.8 | 1,599.5 | 1,575 | 1,582.6 | 11,403 | 11,38,74,880.3 | 56,979 |
27-Oct-2025 | 1,582.6 | 1,637.8 | 1,576.6 | 1,627.8 | 8,127 | 11,76,19,983.5 | 46,507 |
28-Oct-2025 | 1,627.8 | 1,660 | 1,598.8 | 1,628.4 | 10,592 | 32,36,16,883.6 | 1,61,118 |
A company spokesperson said the nod from a regulator of ANVISA’s stature is a strong validation of its manufacturing standards and quality systems.
Eris had acquired the rights from Novartis AG, Switzerland, through an assignment deed dated November 27, 2019.
The shares were sold at an average price of ₹1,201 each, totalling ₹1,187.41 Crore. Infinity Partners acquired these shares.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
